Advertisement

Journal of Parasitic Diseases

, Volume 43, Issue 2, pp 167–175 | Cite as

Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease

  • George Vasquez-RiosEmail author
  • Roberto Pineda-Reyes
  • Juan Pineda-Reyes
  • Ricardo Marin
  • Eloy F. Ruiz
  • Angélica Terashima
Review Article

Abstract

Strongyloides stercoralis hyperinfection syndrome (SHS) is a life-threatening condition that warrants early detection and management. We describe the pathogenesis, organ-specific clinical manifestations, and risk factors associated to this condition. A comprehensive review of the literature was conducted in PubMed, LILACS, EBSCO and SciELO by using the keywords: “hyperinfection syndrome”; “Strongyloides stercoralis”; “disseminated strongyloidiasis”; “systemic strongyloidiasis”, “pathogenesis” and “pathophysiology”. Relevant articles on this topic were evaluated and included by consensus. Also, a secondary search of the literature was performed. Articles in English and Spanish language were included. SHS has been described in tropical and sub-tropical regions. However, there is growing evidence of cases detected in developed countries favored by increasing migration and the advance in immunosuppressive therapies for oncologic and inflammatory diseases. SHS is characterized by massive multiplication of larvae, typically in immunocompromised hosts. Clinical manifestations vary according to the organ involved and include diarrhea, intestinal bleeding, alveolar hemorrhages, heart failure, jaundice, bacteremia among others. Despite advances in the understanding of this condition, fatality rates are near 90%. Clinicians should consider SHS in the differential diagnosis of acutely ill patients with multiple organ damage and epidemiological risk factors. Adverse outcomes are common, especially with delayed anti-parasitic treatment.

Keywords

Strongyloidiasis Autoinfection Massive infection Soil-transmitted helminths Clinical manifestations 

Notes

Acknowledgements

The authors would like to express their gratitude to the Laboratory of Parasitology at the Alexander von Humboldt Tropical Medicine Institute for their support to the elaboration of this manuscript.

Author’s contribution

GVR and RPR drafted the manuscript. GVR, RPR, JPR, RM, EFR and AT critically reviewed the literature, designed the study and made significant contributions to it. AT provided expert consultation for this topic. All the authors reviewed the manuscript and approved the final version.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. Abdalhamid BA, Al Abadi AN, Al Saghier MI, Joudeh AA, Shorman MA, Amr SS (2015) Strongyloides stercoralis infection in kidney transplant recipients. Saudi J Kidney Dis Transplant 26(1):98–102CrossRefGoogle Scholar
  2. Al Malki MM, Song JY (2016) Strongyloides hyperinfection syndrome following haematopoietic stem cell transplantation. Br J Haematol 172(4):496CrossRefGoogle Scholar
  3. Alizadeh-Sani Z, Vakili-Zarch A, Kiavar M, Bahadorian B, Nabavi A (2013) Eosinophilic endomyocardial fibrosis and Strongyloides stercoralis: a case report. Res Cardiovasc Med 2(2):104–105CrossRefGoogle Scholar
  4. Alsharif A, Sodhi A, Murillo LC, Headley AS, Kadaria D (2015) Wait!!! no steroids for this asthma. Am J Case Rep 16:398–400CrossRefGoogle Scholar
  5. Altintop L, Cakar B, Hokelek M, Bektas A, Yildiz L, Karaoglanoglu M (2010) Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report. Ann Clin Microbiol Antimicrob 9:27CrossRefGoogle Scholar
  6. Anuradha R, Munisankar S, Bhootra Y, Jagannathan J, Dolla C, Kumaran P et al (2015a) Systemic cytokine profiles in Strongyloides stercoralis infection and alterations following treatment. Infect Immun 84(2):425–431CrossRefGoogle Scholar
  7. Anuradha R, Munisankar S, Dolla C, Kumaran P, Nutman TB, Babu S (2015b) Parasite antigen-specific regulation of Th1, Th2, and Th17 responses in Strongyloides stercoralis. J Immunol 195(5):2241–2250CrossRefGoogle Scholar
  8. Barros N, Montes M (2014) Infection and hyperinfection with Strongyloides stercoralis: clinical presentation, etiology of disease, and treatment options. Curr Trop Med Rep 1(4):223–228CrossRefGoogle Scholar
  9. Barros N, Woll F, Watanabe L, Montes M (2012) Are increased Foxp3 + regulatory T cells responsible for immunosuppression during HTLV-1 infection? Case reports and review of the literature. BMJ Case Report, pp 1–5Google Scholar
  10. Basile A, Simzar S, Bentow J, Antelo F, Shitabata P, Peng SK et al (2010) Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression. J Am Acad Dermatol 63(5):896–902CrossRefGoogle Scholar
  11. Bollela VR, Feliciano C, Teixeira AC, Junqueira AC, Rossi MA (2013) Fulminant gastrointestinal hemorrhage due to Strongyloides stercoralis hyperinfection in an AIDS patient. Rev Soc Bras Med Trop 46(1):111–113CrossRefGoogle Scholar
  12. Bonne-Année S, Hess JA, Abraham D (2011) Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model. Immunol Res 51(2–3):205–214CrossRefGoogle Scholar
  13. Bonne-Année S, Kerepesi LA, Hess JA, O’Connell AE, Lok JB, Nolan TJ et al (2013) Human and mouse macrophages collaborate with neutrophils to kill larval Strongyloides stercoralis. Infect Immun 81(9):3346–3355CrossRefGoogle Scholar
  14. Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J et al (2013) Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 13:78CrossRefGoogle Scholar
  15. Buonfrate D, Formenti F, Perandin F, Bisoffi Z (2015) Novel approaches to the diagnosis of Strongyloides stercoralis infection. Clin Microbiol Infect 21(6):543–552CrossRefGoogle Scholar
  16. Centers for Disease Control and Prevention (2015) Global health, division of parasitic diseases. Parasites-strongyloides, biology. [cited 2018 Aug 28]. https://www.cdc.gov/parasites/strongyloides/biology.html
  17. Dacal E, Saugar JM, Soler T, Azcárate JM, Jiménez MS, Merino FJ et al (2018) Parasitological versus molecular diagnosis of strongyloidiasis in serial stool samples: how many? J Helminthol 92(1):12–16CrossRefGoogle Scholar
  18. de Paola, Dias L, Da Silva J (1962) Enteritis due to Strongyloides stercoralis. A report of 5 fatal cases. Am J Dig Dis 7:1086–98Google Scholar
  19. Fakhar M, Gholami Z, Banimostafavi ES, Madjidi H (2010) Respiratory hyperinfection caused by Strongyloides stercoralis in a patient with pemphigus vulgaris and minireview on diagnosis and treatment of strongyloidiasis. Comp Clin Pathol 19(6):621–625CrossRefGoogle Scholar
  20. Forrer A, Khieu V, Schär F, Hattendorf J, Marti H, Neumayr A et al (2017) Strongyloides stercoralis is associated with significant morbidity in rural Cambodia, including stunting in children. PLoS Negl Trop Dis 11(10):e0005685CrossRefGoogle Scholar
  21. Galioto AM, Hess JA, Nolan TJ, Schad GA, Lee JJ, Abraham D (2006) Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval Strongyloides stercoralis in mice. Infect Immun 74(10):5730–5738CrossRefGoogle Scholar
  22. Genta RM (1989) Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 11(5):755–767CrossRefGoogle Scholar
  23. Geri G, Rabbat A, Mayaux J, Zafrani L, Chalumeau-Lemoine L, Guidet B et al (2015) Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature. Infection 43(6):691–698CrossRefGoogle Scholar
  24. Glendinning L, Nausch N, Free A, Taylor DW, Mutapi F (2014) The microbiota and helminths: sharing the same niche in the human host. Parasitology 141(10):1255–1271CrossRefGoogle Scholar
  25. Greaves D, Coggle S, Pollard C, Aliyu SH, Moore EM (2013) Strongyloides stercoralis infection. BMJ 347(7919):1–6Google Scholar
  26. Hays R, Giacomin P, Olma L, Esterman A, McDermott R (2017) The relationship between treatment for Strongyloides stercoralis infection and type 2 diabetes mellitus in an Australian aboriginal population: a three-year cohort study. Diabetes Res Clin Pract 134:8–16CrossRefGoogle Scholar
  27. Herrera J, Marcos L, Terashima A, Alvarez H, Samalvides F, Gotuzzo E (2006) Factores asociados a la Infección por Strongyloides stercoralis en individuos de una zona endémica en el Perú. Rev Gastroenterol Peru 26(4):357–362PubMedGoogle Scholar
  28. Hoy WE, Roberts NJ Jr, Bryson MF, Bowles C, Lee JC, Rivero AJ et al (1981) Transmission of strongyloidiasis by kidney transplant? disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA 246(17):1937–1939CrossRefGoogle Scholar
  29. Hübner MP, Layland LE, Hoerauf A (2013) Helminths and their implication in sepsis—a new branch of their immunomodulatory behaviour? Pathog Dis 69(2):127–141CrossRefGoogle Scholar
  30. Infante R, Terashima A, Maguina C, Tello C, Alvarez H, Gotuzzo E (1998) Estudio clínico parasitológico de pacientes con autoinfección por Strongyloides stercoralis en el Hospital Cayetano Heredia 1973–1991. Rev Gastroenterol Perú 18:37–41Google Scholar
  31. Izquierdo I, Briones J, Lluch R, Arqueros C, Martino R (2013) Fatal Strongyloides hyperinfection complicating a gram-negative sepsis after allogeneic stem cell transplantation: a case report and review of the literature. Case Rep Hematol 2013:860976PubMedPubMedCentralGoogle Scholar
  32. Jorgensen T, Montresor A, Savioli L (1996) Effectively controlling strongyloidiasis. Parasitol Today 12(4):164CrossRefGoogle Scholar
  33. Keiser PB, Nutman TB (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17(1):208–217CrossRefGoogle Scholar
  34. Ketzis JK, Conan A (2017) Estimating occurrence of Strongyloides stercoralis in the Caribbean island countries: implications for monitoring and control. Acta Trop 171:90–95CrossRefGoogle Scholar
  35. Khushman M, Morris MI, Diaz L, Goodman M, Pereira D, Fuller K et al (2017) Syndrome of inappropriate anti-diuretic hormone secretion secondary to Strongyloides stercoralis infection in an allogeneic stem cell transplant patient: a case report and literature review. Transplant Proc 49(2):373–377CrossRefGoogle Scholar
  36. Kim JH, Kim DS, Yoon YK, Sohn JW, Kim MJ (2016) Donor-derived strongyloidiasis infection in solid organ transplant recipients: a review and pooled analysis. Transplant Proc 48(7):2442–2449CrossRefGoogle Scholar
  37. Kinjo T, Nabeya D, Nakamura H, Haranaga S, Hirata T, Nakamoto T et al (2015) Acute respiratory distress syndrome due to Strongyloides stercoralis infection in a patient with cervical cancer. Intern Med 54(1):83–87CrossRefGoogle Scholar
  38. Kishimoto K, Hokama A, Hirata T, Ihama Y, Nakamoto M, Kinjo N et al (2008) Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. World J Gastroenterol 14(11):1768–1773CrossRefGoogle Scholar
  39. Lai CP, Hsu YH, Wang JH, Lin CM (2002) Strongyloides stercoralis infection with bloody pericardial effusion in a non-immunosuppressed patient. Circ J 66(6):613–614CrossRefGoogle Scholar
  40. Luvira V, Trakulhun K, Mungthin M, Naaglor T, Chantawat N, Pakdee W et al (2016) Comparative diagnosis of strongyloidiasis in immunocompromised patients. Am J Trop Med Hyg 95(2):401–404CrossRefGoogle Scholar
  41. Makker J, Balar B, Niazi M, Daniel M (2015) Strongyloidiasis: a case with acute pancreatitis and a literature review. World J Gastroenterol 21(11):3367–3375CrossRefGoogle Scholar
  42. Man WH, de Steenhuijsen Piters WA, Bogaert D (2017) The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol 15(5):259–270CrossRefGoogle Scholar
  43. Marathe A, Date V (2008) Strongyloides stercoralis hyperinfection in an immunocompetent patient with extreme eosinophilia. J Parasitol 94(3):759–760CrossRefGoogle Scholar
  44. Marcos LA, Terashima A, DuPont HL, Gotuzzo E (2008) Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg 102(4):314–318CrossRefGoogle Scholar
  45. Marcos LA, Terashima A, Canales M, Gotuzzo E (2011) Update on strongyloidiasis in the immunocompromised host. Curr Infect Dis Rep 13(1):35–46CrossRefGoogle Scholar
  46. Mazhar M, Ali IA, Agudelo Higuita NI (2017) Strongyloides hyperinfection in a renal transplant patient: always be on the lookout. Case Rep Infect Dis 2017:2953805PubMedPubMedCentralGoogle Scholar
  47. Mejia R, Nutman TB (2012) Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 25(4):458–463CrossRefGoogle Scholar
  48. Merzkani M, Uppal NN, Ross DW, Gautam-Goyal P, Malhotra P, Shah HH et al (2017) Strongyloides stercoralis-associated tip variant focal segmental glomerulosclerosis. Kidney Int Rep 3(1):14–18CrossRefGoogle Scholar
  49. Miyazaki M, Tamura M, Kabashima N, Serino R, Shibata T, Miyamoto T et al (2010) Minimal change nephrotic syndrome in a patient with strongyloidiasis. Clin Exp Nephrol 14(4):367CrossRefGoogle Scholar
  50. Mokhlesi B, Shulzhenko O, Garimella PS, Kuma L, Monti C (2004) Pulmonary Strongyloidiasis: the varied clinical presentations. Clin Pulm Med 11(1):6–13CrossRefGoogle Scholar
  51. Montes M, Sanchez C, Verdonck K, Lake JE, Gonzalez E, Lopez G et al (2009) Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis 3(6):4–11CrossRefGoogle Scholar
  52. Morgello S, Soifer FM, Lin CS, Wolfe DE (1993) Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature. Acta Neuropathol 86(3):285–288CrossRefGoogle Scholar
  53. Murali A, Rajendiran G, Ranganathan K, Shanthakumari S (2010) Disseminated infection with Strongyloides stercoralis in a diabetic patient. Indian J Med Microbiol 28(4):407–408CrossRefGoogle Scholar
  54. Nabeya D, Haranaga S, Parrott GL, Kinjo T, Nahar S, Tanaka T et al (2017) Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases. BMC Infect Dis 17(1):320CrossRefGoogle Scholar
  55. Nolan MT, Ali F, Sultan T, Mcgavigan AD, Selvanayagam JB, Joseph MX (2013) Loeffler’s endocarditis caused by Strongyloides infection. Int J Cardiol 164(3):19–21CrossRefGoogle Scholar
  56. Nutman TB (2017) Human infection with Strongyloides stercoralis and other related Strongyloides species. Parasitology 144(3):263–273CrossRefGoogle Scholar
  57. Ortega CD, Ogawa NY, Rocha MS, Blasbalg R, Caiado AH, Warmbrand G et al (2010) Helminthic diseases in the abdomen: an epidemiologic and radiologic overview. Radiographics 30(1):253–267CrossRefGoogle Scholar
  58. Pasqualotto AC, Zborowski MF, dos Anjos M, Poloni JA, dos Santos AP, Torelly AP (2009) Strongyloides in the urine. Trans R Soc Trop Med Hyg 103(1):106–107CrossRefGoogle Scholar
  59. Puthiyakunnon S, Boddu S, Li Y, Zhou X, Wang C, Li J et al (2014) Strongyloidiasis—an insight into its global prevalence and management. PLoS Negl Trop Dis 8(8):e3018CrossRefGoogle Scholar
  60. Ribeiro SR, Covre LP, Stringari LL, da Penha Zago-Gomes M, Gomes DC, Pereira FE (2017) Peripheral blood CD4 +/CD25 + regulatory T cells in alcoholic patients with Strongyloides stercoralis infection. Parasitol Res 116(3):1071–1074CrossRefGoogle Scholar
  61. Rodríguez M, Flores P, Ahumada V, Vázquez-Vázquez L, Alvarado-de la Barrera C, Reyes-Terán G (2012) Central nervous system strongyloidiasis and cryptococcosis in an HIV-infected patient starting antiretroviral therapy. Case Rep Med 2012:575470CrossRefGoogle Scholar
  62. Salvador F, Molina I, Sulleiro E, Burgos J, Curran A, Van den Eynde E et al (2013) Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain. Am J Trop Med Hyg 88(6):1196–1202CrossRefGoogle Scholar
  63. Sarangi S, Phillips SD, Burkhart HM (2013) Strongyloides-associated left ventricular thrombus. Ann Thorac Surg 96(4):1487CrossRefGoogle Scholar
  64. Schaible UE, Kaufmann SH (2007) Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 4(5):e115CrossRefGoogle Scholar
  65. Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H et al (2013) Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7(7):e2288CrossRefGoogle Scholar
  66. Siegel MO, Simon GL (2012) Is human immunodeficiency virus infection a risk factor for Strongyloides stercoralis hyperinfection and dissemination. PLoS Negl Trop Dis 6(7):7–9CrossRefGoogle Scholar
  67. Silva ML, Inês Ede J, Souza AB, Dias VM, Guimarães CM, Menezes ER et al (2016) Strongyloides stercoralis infection and cortisol secretion in alcoholic patients. Acta Trop 154:133–138CrossRefGoogle Scholar
  68. Tahapary DL, de Ruiter K, Martin I, Brienen EAT, van Lieshout L, Djuardi Y et al (2017) Effect of anthelmintic treatment on leptin, adiponectin and leptin to adiponectin ratio: a randomized-controlled trial. Nutr Diabetes 7(10):e289CrossRefGoogle Scholar
  69. Takele Y, Adem E, Getahun M, Tajebe F, Kiflie A, Hailu A et al (2016) Malnutrition in healthy individuals results in increased mixed cytokine profiles, altered neutrophil subsets and function. PLoS ONE 11(8):1–18CrossRefGoogle Scholar
  70. Teixeira MC, Pacheco FT, Souza JN, Silva ML, Inês EJ, Soares NM (2016) Strongyloides stercoralis infection in alcoholic patients. Biomed Res Int 2016:4872473CrossRefGoogle Scholar
  71. Terashima A, Alvarez H, Tello R, Infante R, Freedman DO, Gotuzzo E (2002) Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection. Int J Infect Dis 6(1):28–30CrossRefGoogle Scholar
  72. Thaden J, Cassar A, Vaa B, Phillips S, Burkhart H, Aubry M et al (2013) Eosinophilic endocarditis and Strongyloides stercoralis. Am J Cardiol 112(3):461–462CrossRefGoogle Scholar
  73. Toledo R, Muñoz-Antoli C, Esteban JG (2015) Strogyloidiasis with emphasis on human infections and its different clinical forms. Adv Parasitol 88:165–241CrossRefGoogle Scholar
  74. Upadhyay D, Corbridge T, Jain M, Shah R (2001) Pulmonary hyperinfection syndrome with Strongyloides stercoralis. Am J Med 110(2):167–169CrossRefGoogle Scholar
  75. Vadlamudi RS, Chi DS, Krishnaswamy G (2006) Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy 4:8CrossRefGoogle Scholar
  76. Watanabe K, Noda K, Hamano S, Koga M, Kishihara K, Nomoto K et al (2000) The crucial role of granulocytes in the early host defense against Strongyloides ratti infection in mice. Parasitol Res 86(3):188–193CrossRefGoogle Scholar
  77. Weiser JA, Scully BE, Bulman WA, Husain S, Grossman ME (2011) Periumbilical parasitic thumbprint purpura: strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant. Transpl Infect Dis 13(1):58–62CrossRefGoogle Scholar
  78. Wirk B, Wingard JR (2009) Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis 11(2):143–148CrossRefGoogle Scholar
  79. Woll F, Gotuzzo E, Montes M (2013) Strongyloides stercoralis infection complicating the central nervous system. Handb Clin Neurol 114:229–234CrossRefGoogle Scholar
  80. Zaiss MM, Harris NL (2016) Interactions between the intestinal microbiome and helminth parasites. Parasite Immunol 38(1):5–11CrossRefGoogle Scholar

Copyright information

© Indian Society for Parasitology 2019

Authors and Affiliations

  • George Vasquez-Rios
    • 1
    Email author
  • Roberto Pineda-Reyes
    • 1
  • Juan Pineda-Reyes
    • 2
  • Ricardo Marin
    • 2
  • Eloy F. Ruiz
    • 1
  • Angélica Terashima
    • 1
    • 2
  1. 1.Laboratory of ParasitologyInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano HerediaLimaPeru
  2. 2.Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano HerediaLimaPeru

Personalised recommendations